Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Clin Invest ; 129(12): 5123-5136, 2019 12 02.
Artículo en Inglés | MEDLINE | ID: mdl-31430258

RESUMEN

Patients with paroxysmal nocturnal hemoglobinuria (PNH) have a clonal population of blood cells deficient in glycosylphosphatidylinositol-anchored (GPI-anchored) proteins, resulting from a mutation in the X-linked gene PIGA. Here we report on a set of patients in whom PNH results instead from biallelic mutation of PIGT on chromosome 20. These PIGT-PNH patients have clinically typical PNH, but they have in addition prominent autoinflammatory features, including recurrent attacks of aseptic meningitis. In all these patients we find a germ-line point mutation in one PIGT allele, whereas the other PIGT allele is removed by somatic deletion of a 20q region comprising maternally imprinted genes implicated in myeloproliferative syndromes. Unlike in PIGA-PNH cells, GPI is synthesized in PIGT-PNH cells and, since its attachment to proteins is blocked, free GPI is expressed on the cell surface. From studies of patients' leukocytes and of PIGT-KO THP-1 cells we show that, through increased IL-1ß secretion, activation of the lectin pathway of complement and generation of C5b-9 complexes, free GPI is the agent of autoinflammation. Eculizumab treatment abrogates not only intravascular hemolysis, but also autoinflammation. Thus, PIGT-PNH differs from PIGA-PNH both in the mechanism of clonal expansion and in clinical manifestations.


Asunto(s)
Proteínas del Sistema Complemento/inmunología , Hemoglobinuria Paroxística/inmunología , Inflamasomas/inmunología , Inflamación/inmunología , Proteínas de la Membrana/genética , Anciano , Alelos , Anticuerpos Monoclonales Humanizados/uso terapéutico , Femenino , Eliminación de Gen , Genes Ligados a X , Alemania , Glicosilfosfatidilinositoles/metabolismo , Hemólisis/efectos de los fármacos , Humanos , Japón , Leucocitos/inmunología , Masculino , Persona de Mediana Edad , Mutación , Mutación Puntual , Células THP-1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA